UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
HealthcareAdd-on
UCB→Neurona Therapeutics
Apr 17, 2026
Kailera Therapeutics Upsized IPO Raises $625M
Announced
HealthcareOther
Deal Overview
Kailera Therapeutics’ upsized IPO is reported to bring in $625M to fund a pipeline of injectable and oral obesity drugs. The deal is described as an IPO intended to support development of obesity therapeutics.
Key Details
- Target
- Kailera Therapeutics
- Deal Size
- Over $100M
Powered by Tentt
Source healthcare deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Florida system raises $100M for new ED
HealthcareFloridaOther
Jackson Memorial Hospital
Apr 17, 2026
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer - Business Wire
HealthcareOther
Gilead→Arcellx
Apr 17, 2026
Panthera Biopartners Expands European Footprint with Acquisition of Hungary’s Leading Clinical Research Organisation OEC - EIN Presswire
HealthcarePlatform
Panthera Biopartners→OEC
Apr 17, 2026
Centessa Pharmaceuticals plc — SEC PREM14A Filing
HealthcareMerger
Lilly→Centessa Pharmaceuticals
Apr 17, 2026